この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2004/4/151 分で読めます
Notice of Approval of New Animal Drug Application; Ceftiofur
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Pharmacia &Upjohn, Co. The supplemental NADA provided revised susceptibility information for equine pathogens listed in the clinical microbiology section of labeling for ceftiofur sodium sterile powder for injection and added interpretive criteria. The applicable section of the regulations did not require amendment.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →